SUMMIT THERAPEUTICS PLC's ticker is SMMT and the CUSIP is 86627R102. A total of 15 filers reported holding SUMMIT THERAPEUTICS PLC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $126,000 | -57.9% | 51,549 | +122.4% | 0.00% | – |
| Q1 2018 | $299,000 | -73.0% | 23,178 | -76.8% | 0.00% | -100.0% |
| Q4 2017 | $1,107,000 | +14.4% | 99,873 | +29.5% | 0.00% | +100.0% |
| Q3 2017 | $968,000 | +12.0% | 77,114 | +1.7% | 0.00% | -50.0% |
| Q2 2017 | $864,000 | -19.8% | 75,823 | -6.5% | 0.00% | 0.0% |
| Q1 2017 | $1,077,000 | +32.1% | 81,093 | -14.8% | 0.00% | 0.0% |
| Q4 2016 | $815,000 | – | 95,172 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 212,018 | $2,349,000 | 0.28% |
| Granite Point Capital Management, L.P. | 242,113 | $2,683,000 | 0.26% |
| LANSDOWNE PARTNERS (UK) LLP | 1,596,666 | $17,691,000 | 0.16% |
| Point72 Asset Management, L.P. | 785,600 | $8,704,000 | 0.04% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 80,000 | $886,000 | 0.02% |
| AXA S.A. | 282,760 | $3,133,000 | 0.01% |
| Polar Capital LLP | 100,000 | $1,108,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 144,083 | $1,595,000 | 0.01% |
| First Eagle Investment Management, LLC | 194,900 | $2,159,000 | 0.01% |
| Alyeska Investment Group, L.P. | 50,000 | $554,000 | 0.00% |